Antharis Therapeutics
- Biotech or pharma, therapeutic R&D
Antharis Therapeutics is a private biopharmaceutical company located in San Diego, California and is engaged in the discovery and development of monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) as next-generation treatments for oncology and other unmet medical needs. Antharis has 5+ advanced assets with one ADC targeting CDH17 scheduled to enter the clinic over the next year. We own exclusive global rights to all of our assets with patent protection into at least 2044 and a strong balance sheet with projected runway through 2027. Antharis Therapeutics was recently named the 2025 Monoclonal Antibody Development Company of the Year.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}